再生伤口护理市场－全球产业规模、份额、趋势、机会和预测，按类型、伤口类型、最终用户、地区和竞争细分，2020 年至 2030 年

2024 年全球再生伤口护理市场价值为 102.7 亿美元，预计到 2030 年将达到 145.4 亿美元，预测期内的复合年增长率为 5.97%。全球再生伤口护理市场正在经历显着增长，主要是因为烧伤、受伤、擦伤和溃疡等造成的伤口发生率不断上升。此外，老年人口不断增长，他们容易受到各种伤害和跌倒的影响，预计这将增加对再生伤口护理市场的需求。在老年族群中，由于各种其他相关疾病，伤口癒合过程缓慢，导致对可以加速伤口癒合的产品的需求，从而支持市场成长。根据联合国经济和社会事务部人口司的数据，到 2050 年，65 岁或以上人口数量预计将达到 15.489 亿。

关键市场驱动因素

慢性病盛行率上升

主要市场挑战

先进再生疗法成本高昂

主要市场趋势

智慧科技在伤口照护中的整合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：临床试验分析

第六章：全球再生伤口护理市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（自体干细胞、生物皮肤替代品、组织/多组织平台、胎儿皮肤、再生伤口护理设备、其他）
  • 依伤口类型（溃疡、手术和创伤性伤口、烧伤）
  • 按最终使用者（医院、门诊手术中心、烧伤护理中心和伤口诊所等）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第七章：北美再生伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第八章：欧洲再生伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
  • B 按类型
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第九章：亚太再生伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第十章：南美洲再生伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 11 章：中东和非洲再生伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 12 章：市场动态

• 驱动程式
• 挑战

第十三章：市场趋势与发展

• 最新动态
• 併购
• 产品发布

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 14 章：SWOT 分析：全球再生伤口护理市场

第 15 章：竞争格局

• DeCell Technologies Inc.
• Avita Medical, Inc.
• Organogenesis, Inc.
• Histogen, Inc.
• RenovoDerm (Nanofiber Solutions, LLC)
• StemsysBio
• Koninklijke DSM NV
• MiMedx Group, Inc.
• 3M Company
• Smith & Nephew PLC

第 16 章：策略建议

第17章调查会社について・免责事项

Global Regenerative Wound Care Market was valued at USD 10.27 billion in 2024 and is expected to reach USD 14.54 billion by 2030 with a CAGR of 5.97% during the forecast period. The global market for Regenerative Wound Care is experiencing significant growth, driven by the growing incidence of wounds caused due to burns, injuries, soars & ulcers, among others. Additionally, the growing geriatric population which is susceptible to various kinds of injuries and falls is expected to increase the demand for regenerative wound care market. In the elderly population, due to various other associated conditions the wound healing process is slow, leading to the demand for products which can bring about faster wound healing, thereby supporting market growth. According to the United Nations, Department of Economic and Social Affairs, Population Division, the number of people aged 65 years or above is expected to reach 1548.9 million by 2050.

Key Market Drivers

Rising Prevalence of Chronic Diseases

One of the most significant drivers of the regenerative wound care market is the growing prevalence of chronic diseases, notably diabetes, obesity, and cardiovascular disorders. These conditions are known to impair wound healing due to poor circulation, reduced immune response, and other metabolic dysfunctions. Among them, diabetes mellitus is the leading cause of chronic wounds, particularly diabetic foot ulcers (DFUs), which are notoriously difficult to treat. Globally, diabetes affects over 537 million adults, and the number is expected to rise to 643 million by 2030 and 783 million by 2045, according to the International Diabetes Federation (IDF). In the U.S. alone, the CDC reports that over 37 million Americans are diabetic, and 96 million more are prediabetic. Around 15% of diabetic patients develop foot ulcers at some point in their lives, which are susceptible to infections and often require amputation if not effectively treated.

This growing burden is driving demand for advanced and regenerative wound care technologies that can stimulate healing in patients with impaired tissue regeneration. Governments are responding to this healthcare burden with public health initiatives. For instance, the CDC's National Diabetes Prevention Program focuses on early detection, lifestyle intervention, and management strategies that indirectly push for better wound care services. Moreover, the World Health Organization (WHO) has emphasized the growing need for chronic wound care as part of universal health coverage. This global health push is propelling investments in regenerative wound treatments such as stem cell therapies, extracellular matrix products, and skin grafts, especially in middle-income countries seeking to modernize their healthcare systems.

Key Market Challenges

High Cost of Advanced Regenerative Therapies

Despite the promising nature of regenerative wound care solutions, cost remains a formidable barrier to their widespread adoption. Advanced therapies such as stem cell treatments, tissue-engineered skin, and bioactive wound dressings are considerably more expensive than traditional wound care products like gauze or hydrocolloid dressings. For example, the cost of a single application of a bioengineered skin substitute can range from $500 to $3,000, and most treatments require multiple applications. This cost is particularly prohibitive in low- and middle-income countries, where health insurance coverage may be limited or non-existent.

Even in high-income nations, insurance reimbursement can be inconsistent. While programs like Medicare and Medicaid in the U.S. have approved certain products for reimbursement, coverage limitations and complex billing processes often deter hospitals from fully adopting these treatments. In many cases, patients are required to bear out-of-pocket expenses, creating disparities in access. Although governments are attempting to ease the financial burden through subsidies, value-based care models, and innovative payment structures, a lack of uniform policy across regions continues to restrict market penetration. This challenge calls for stronger public-private collaboration to make regenerative wound therapies more economically viable for healthcare systems globally.

Key Market Trends

Integration of Smart Technologies in Wound Care

A key trend in reshaping the regenerative wound care landscape is the integration of digital health and smart technologies into wound management protocols. This includes the use of wearable sensors, artificial intelligence (AI), telehealth platforms, and remote monitoring tools for real-time wound assessment. Smart bandages equipped with biosensors can monitor wound pH, temperature, and moisture levels, providing timely insights into infection risk and healing progress. AI-based diagnostic platforms can assess wounds using image processing and machine learning, reducing diagnostic variability among clinicians and enabling standardized care.

Governments are actively promoting such innovations through health technology initiatives. For instance, the UK's National Health Service (NHS) launched the Wound Care Innovation programme as part of its Long Term Plan to reduce chronic wound burden and treatment costs. Similarly, the U.S. FDA has streamlined digital health regulations via its Digital Health Center of Excellence, encouraging innovation in remote wound care management. These smart technologies not only enhance patient outcomes but also reduce the frequency of hospital visits and the associated costs of chronic wound treatment. This trend is especially relevant in the post-COVID-19 era, where remote patient management has gained acceptance as a viable method for ongoing care, particularly among the elderly and immobile patient populations. The integration of these technologies is set to transform wound care from reactive treatment to proactive management, enabling more effective and efficient care pathways for chronic wound patients.

Key Market Players

• DeCell Technologies Inc.
• Avita Medical, Inc.
• Organogenesis, Inc.
• Histogen, Inc.
• RenovoDerm (Nanofiber Solutions, LLC)
• StemsysBio
• Koninklijke DSM N.V.
• MiMedx Group, Inc.
• 3M Company
• Smith & Nephew PLC

Report Scope:

In this report, the Global Regenerative Wound Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Regenerative Wound Care Market, By Type:

• Autologous Stem Cells
• Biological Skin Substitutes
• Tissue/Multiple Tissue Platform
• Fetal Skin
• Regenerative Wound Care Devices
• Others

Regenerative Wound Care Market, By Wound Type:

• Ulcers
• Surgical & Traumatic Wounds
• Burns

Regenerative Wound Care Market, By End User:

• Hospitals
• Ambulatory Surgical Centers
• Burn Care Centers & Wound Clinics
• Others

Regenerative Wound Care Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Regenerative Wound Care Market.

Available Customizations:

Global Regenerative Wound Care Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

• 5.1. Ongoing Clinical Trials
• 5.2. Completed Clinical Trials
• 5.3. Terminated Clinical Trials
• 5.4. Breakdown of Pipeline, By Development Phase
• 5.5. Breakdown of Pipeline, By Status
• 5.6. Breakdown of Pipeline, By Study Application
• 5.7. Breakdown of Pipeline, By Region
• 5.8. Clinical Trials Heat Map

6. Global Regenerative Wound Care Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
  • 6.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
  • 6.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
  • 6.2.4. By Region
  • 6.2.5. By Company (2024)
• 6.3. Market Map

7. North America Regenerative Wound Care Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
  • 7.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
  • 7.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Regenerative Wound Care Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Wound Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Canada Regenerative Wound Care Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Wound Type
      • 7.3.2.2.3. By End User
  • 7.3.3. Mexico Regenerative Wound Care Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Wound Type
      • 7.3.3.2.3. By End User

8. Europe Regenerative Wound Care Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. B By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
  • 8.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
  • 8.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
  • 8.2.4. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Regenerative Wound Care Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Wound Type
      • 8.3.1.2.3. By End User
  • 8.3.2. Germany Regenerative Wound Care Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Wound Type
      • 8.3.2.2.3. By End User
  • 8.3.3. United Kingdom Regenerative Wound Care Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Wound Type
      • 8.3.3.2.3. By End User
  • 8.3.4. Italy Regenerative Wound Care Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Wound Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Spain Regenerative Wound Care Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Wound Type
      • 8.3.5.2.3. By End User

9. Asia-Pacific Regenerative Wound Care Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
  • 9.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
  • 9.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
  • 9.2.4. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Regenerative Wound Care Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Wound Type
      • 9.3.1.2.3. By End User
  • 9.3.2. India Regenerative Wound Care Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Wound Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Japan Regenerative Wound Care Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Wound Type
      • 9.3.3.2.3. By End User
  • 9.3.4. South Korea Regenerative Wound Care Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By Wound Type
      • 9.3.4.2.3. By End User
  • 9.3.5. Australia Regenerative Wound Care Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Type
      • 9.3.5.2.2. By Wound Type
      • 9.3.5.2.3. By End User

10. South America Regenerative Wound Care Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
  • 10.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
  • 10.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Regenerative Wound Care Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Wound Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Argentina Regenerative Wound Care Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Wound Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Colombia Regenerative Wound Care Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Wound Type
      • 10.3.3.2.3. By End User

11. Middle East and Africa Regenerative Wound Care Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
  • 11.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
  • 11.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
  • 11.2.4. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Regenerative Wound Care Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Type
      • 11.3.1.2.2. By Wound Type
      • 11.3.1.2.3. By End User
  • 11.3.2. Saudi Arabia Regenerative Wound Care Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Type
      • 11.3.2.2.2. By Wound Type
      • 11.3.2.2.3. By End User
  • 11.3.3. UAE Regenerative Wound Care Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Type
      • 11.3.3.2.2. By Wound Type
      • 11.3.3.2.3. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Mergers & Acquisitions
• 13.3. Product Launches

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products/Services

14. SWOT Analysis: Global Regenerative Wound Care Market

15. Competitive Landscape

• 15.1. DeCell Technologies Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Avita Medical, Inc.
• 15.3. Organogenesis, Inc.
• 15.4. Histogen, Inc.
• 15.5. RenovoDerm (Nanofiber Solutions, LLC)
• 15.6. StemsysBio
• 15.7. Koninklijke DSM N.V.
• 15.8. MiMedx Group, Inc.
• 15.9. 3M Company
• 15.10. Smith & Nephew PLC

16. Strategic Recommendations

17. About Us & Disclaimer